Skip to main content

Dr. Yan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Yan's full profile

Already have an account?

  • Office

    4721 Dallas Ranch Rd
    Antioch, CA 94531
    Phone+1 925-778-0679
    Fax+1 925-778-3567

Education & Training

  • Case Western Reserve University
    Case Western Reserve UniversityPh.D., Molecular Biology and Microbiology, 1999 - 2005
  • Peking Union Medical College
    Peking Union Medical CollegeClass of 1998
  • Shandong Medical University
    Shandong Medical UniversityB.Sc., Medical Science, 1990 - 1996

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2011 - 2026

Awards, Honors, & Recognition

  • 2nd Place, Resident Research Abstract Competition New York Chapter, American College of Physicians, 2011
  • Oncology Young Investigator Award AACR-Bristol-Myers Squibb, 2005
  • Award for Cancer Research Milheim Foundation, 2005

Publications & Presentations

PubMed

Journal Articles

  • HER2 aberrations in cancer: Implications for therapy  
    Yan M, Parker BA, Schwab R, Kurzrock R, Cancer Treat Rev, 7/1/2014
  • Synthetic triterpenoid induces 15-PGDH expression and suppresses inflammation-driven colon carcinogenesis  
    Choi SH, Kim BG, Robinson J, Fink S, Yan M, Sporn MB, Markowitz SD, Letterio JJ, J Clin Invest, 6/1/2014
  • CD20-positive plasmablastic lymphoma with excellent response to bortezomib combined with rituximab  
    Yan M, Dong Z, Zhao F, Chauncey T, Deauna-Limayo D, Wang-Rodriguez J, Liu D, Wang HY, Pilz R, Eur J Haematol, 2/14/2014
  • Join now to see all

Abstracts/Posters

  • HER2 distribution in diverse tumors: Analysis of 11,493 nonbreast, nongastric cancers.
    David Arguello, Sherri Z. Millis, Zoran Gatalica, Min Yan, Razelle Kurzrock, J Clin Oncol, 1/1/2014
  • Prostaglandin Transporter, Down-Regulated In Colon Cancer, Mediates Prostaglandin Influx For Intracellular Degradation. Poster.
    Yan M, Markowitz S, Annual Meeting of Medical Society of the State of New York, Rochester, NY, 1/1/2009
  • 15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers. Poster.
    Yan M, Rerko RM, Platzer P, Dawson D, Willis J, Tong M, Lawrence E, Lutterbaugh J, Lu S, Willson JK, Luo G, Hensold J, Tai HH, Wilson K, Markowitz SD, AACR Annual Meeting, 1/1/2005

Lectures

  • Invited Speaker (Distinguished Abstract Plenary), Digestive Disease Week 
    Washington Convention Center - 5/1/2007
  • Invited Speaker, AACR 
    4/1/2005

Press Mentions

  • Prof. Yongmei Yin at 2023 ESMO: SKB264 (MK-2870), an innovativeTROP2-ADC Originating from Chinese Biotech, Achieves Remarkable Success in Overcoming the Therapeutic Impasse in HR+/HER2- Metastatic Breast Cancer
    Prof. Yongmei Yin at 2023 ESMO: SKB264 (MK-2870), an innovativeTROP2-ADC Originating from Chinese Biotech, Achieves Remarkable Success in Overcoming the Therapeutic Impasse in HR+/HER2- Metastatic Breast CancerOctober 27th, 2023